- Recent Funding
- Investors
- David Hamamoto
David Hamamoto portfolio
David Hamamoto has 1 portfolio company on record at Recent Funding.
About this page
It is an angel investor. Its most recent investment on record is Life House's $30M Series B+ round in January 2020, alongside Sound Ventures, Trinity Ventures, Thayer Investment Partners and 6 others. That company is in Health and bio.
What David Hamamoto invests in
- Health and bio · 1 · 100%
- Consumer and social · 1 · 100%
How David Hamamoto invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $30M |
David Hamamoto portfolio companies
LLife House$30MSeries B+ · Jan 2020
| Company | Round with David Hamamoto | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $30M | $100M | Dec 6, 2021 Series B+ |
Most frequent co-investors
TTiger Global Management1 shared round · last Jan 24, 2020
GGlobal Founders Capital1 shared round · last Jan 24, 2020
SSound Ventures1 shared round · last Jan 24, 2020
CComcast Ventures1 shared round · last Jan 24, 2020
TTrinity Ventures1 shared round · last Jan 24, 2020
TThayer Investment Partners1 shared round · last Jan 24, 2020
JJLL Spark1 shared round · last Jan 24, 2020
AAshton Kutcher1 shared round · last Jan 24, 2020
- JJim Ketai1 shared round · last Jan 24, 2020
Similar investors
JJoe Gebbia2 companies
- TTanmay Bhat3 companies · 3 deals in 12 mo
DDavid Friedberg3 companies · 2 deals in 12 mo
BBoon Hwee Koh3 companies
EEoghan McCabe3 companies
HHanno Renner3 companies
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name David Hamamoto. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists David Hamamoto, which is a subset of its real portfolio. API: /api/v1/investors/david-hamamoto (get a free API key). More: the most active VC firms and new venture capital funds.